Form 4: TransMedics Group CEO Waleed Hassanein Executes Stock Option and Sells Shares Under 10b5-1 Plan

TransMedics Group's CEO, Waleed H. Hassanein, exercised stock options and sold shares of common stock under a pre-arranged Rule 10b5-1 trading plan.

Summary

• On April 17, 2024, Waleed H. Hassanein, CEO of TransMedics Group, Inc., exercised stock options to acquire 4,000 shares of common stock at a price of $13.28 per share.
• Simultaneously, Hassanein sold 4,000 shares of common stock at a weighted average price of $95.12 per share, with individual transactions ranging from $95.07 to $95.33.
• These transactions were executed under a Rule 10b5-1 trading plan established on September 6, 2023.
• Following these transactions, Hassanein directly owns 74,087 shares of common stock and indirectly owns 469,359 shares through the Waleed H. Hassanein Revocable Trust.
• He also directly owns options for 234,000 shares.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the transaction is part of a pre-planned trading strategy and doesn't necessarily reflect a change in the CEO's confidence in the company.

Industry Context

Insider transactions are common, and the use of Rule 10b5-1 plans allows corporate insiders to sell shares over a predetermined period, mitigating concerns about trading on non-public information. The market will likely interpret this as a routine transaction under the plan.

Comparison to Industry Standards

• Comparing this transaction to similar insider sales in the medical device industry, the volume of shares sold is relatively small compared to the CEO's total holdings.
• Companies like Intuitive Surgical (ISRG) and Medtronic (MDT) often see similar insider transactions, but the impact on stock price usually depends on the overall market sentiment and company performance.
• The use of a 10b5-1 plan is a standard practice, aligning with regulatory expectations for transparency and preventing accusations of opportunistic trading.

Stakeholder Impact

• The transaction is unlikely to have a significant impact on shareholders as it was pre-planned.
• Employees may see it as a routine transaction.
• Customers, suppliers, and creditors are unlikely to be affected.

Key Dates